Neuraxpharm Group, a European specialty pharmaceutical company focused on the central nervous system, has expanded its operations in Southern Europe with the launch of Neuraxpharm Portugal, it was reported yesterday.
The new office will be part of the company's Southern European Region that includes Italy, Spain and now Portugal.
Javier Mercade, general manager for Italy and Spain, was named as head of the Southern Region earlier this year, which will include Spain, Italy and Portugal. The company has also named Teng Dias as commercial director of the Portugal business.
CStone Pharmaceuticals names new general manager for Greater China and head of Commercial
Savara Names van Es-Johansson to Board of Directors
Repare Therapeutics Appoints Steve Forte as CFO and Samarth Kulkarni to Its Board of Directors
Geron Names Kapur as EVP of Corporate Strategy and Chief Commercial Officer
Wave Neuroscience acquires brain treatment technology assets from NBRL
Johnson & Johnson names new directors
APR Applied Pharma Research's APR-TD011 granted US FDA Orphan Drug Designation